Tarique Hussain, Bie Tan, Yulong Yin, Francois Blachier, Myrlene C B Tossou, Najma Rahu, Oxid Med Cell Longev
In preclinical models, Dihexa demonstrated superior pharmacokinetic properties, including good oral activity and effective BBB penetration, along with enhanced metabolic stability with a half-life of 335.5 minutes
Exacoustos C, Lauriola I, Lazzeri L, De Felice G, Zupi E
16mg total 200 mcg per spray Third-party tested Qalitex Identity confirmed Certificate of Analysis Tested by Qalitex 07/17/2026 Tested by Janoshik 11/10/2025 Key Ingredients A stable pentadecapeptide (15 amino acids) studied in relation to cytoprotective mechanisms, nitric oxide system interactions, growth factor expression, and angiogenic pathways
Common side effects are mild injectionsite reactions
Talk with your provider and visit clinicaltrials.gov to find ongoing alopecia areata trials that are recruiting participants